stockhead3d
Health Check: Neuren’s ‘Willy Wonka’ voucher shows how a piece of paper can be worth US$50m
Drug developer Neuren Pharmaceuticals pockets a US$50 million windfall from a so-called 'priority review voucher'.
ASX closes closes up on Sigma-Chemist Warehouse merger; Nine cops protest vote, US markets rallied on Trump's victory — as it happened
The Australian share market bounced back after the ACCC approved the Sigma and Chemist Warehouse merger. Nine felt the wrath ...